(19)
(11) EP 3 228 322 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.06.2019 Bulletin 2019/25

(45) Mention of the grant of the patent:
10.04.2019 Bulletin 2019/15

(21) Application number: 15865520.9

(22) Date of filing: 01.12.2015
(51) International Patent Classification (IPC): 
A61K 31/7125(2006.01)
A61K 39/00(2006.01)
C12N 15/09(2006.01)
 C12N 15/117(2010.01)
A61K 39/39(2006.01)
(86) International application number:
PCT/JP2015/083825
(87) International publication number:
WO 2016/088784 (09.06.2016 Gazette 2016/23)

(54)

ADJUVANT COMPOSITION

HILFSSTOFFZUSAMMENSETZUNG

COMPOSITION D'ADJUVANT

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 02.12.2014 JP 2014244421

(43) Date of publication of application:
11.10.2017 Bulletin 2017/41

(73) Proprietor: Advanced Innovation Development Co. Ltd.
Chiyoda-ku Tokyo, 101-0052 (JP)

(72) Inventors:
  • SEYA, Tsukasa
    Sapporo-shi Hokkaido 060-0808 (JP)
  • MATSUMOTO, Misako
    Sapporo-shi Hokkaido 060-0808 (JP)

(74) Representative: Knoop, Philipp 
VKK Patentanwälte PartG mbB An der Alster 84
20099 Hamburg
20099 Hamburg (DE)


(56) References cited: : 
WO-A1-2008/065752
 WO-A1-2012/014945
   
  • ZUNIGA ET AL: "Attenuated measles virus as a vaccine vector", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 25, no. 16, 29 March 2007 (2007-03-29), pages 2974-2983, XP022004277, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2007.01.064
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).